相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer
Carmine De Angelis et al.
CLINICAL CANCER RESEARCH (2021)
A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancer
Noor Mazin Abdulkareem et al.
FASEB JOURNAL (2021)
Neuropeptide Y Acts Directly on Cartilage Homeostasis and Exacerbates Progression of Osteoarthritis Through NPY2R
Xiaomin Kang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Overcoming Endocrine Resistance in Breast Cancer
Ariella B. Hanker et al.
CANCER CELL (2020)
Higher Serum Neuropeptide Y Levels Are Associated with Metabolically Unhealthy Obesity in Obese Chinese Adults: A Cross-Sectional Study
Hao-Neng Tang et al.
MEDIATORS OF INFLAMMATION (2020)
How GPCR Phosphorylation Patterns Orchestrate Arrestin-Mediated Signaling
Naomi R. Latorraca et al.
CELL (2020)
Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer
Neil Portman et al.
ENDOCRINE-RELATED CANCER (2019)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy
Victoria Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Neuropeptide Y and its Involvement in Chronic Pain
Marta Diaz-delCastillo et al.
NEUROSCIENCE (2018)
GPCRs profiling and identification of GPR110 as a potential new target in HER2+breast cancer
Raksha R. Bhat et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
The Role of Neuropeptide Y in Cardiovascular Health and Disease
Cheryl M. J. Tan et al.
FRONTIERS IN PHYSIOLOGY (2018)
Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction
Jeetendra Kumar Nag et al.
CANCER AND METASTASIS REVIEWS (2018)
CDK4/6 inhibition in breast cancer: current practice and future directions
Sonia Pernas et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
NPY1 Receptors Participate in the Regulation of Myocardial Contractility in Rats
P. M. Masliuko et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer
Maria Teresa Herrera-Abreu et al.
CANCER RESEARCH (2016)
Proteogenomics connects somatic mutations to signalling in breast cancer
Philipp Mertins et al.
NATURE (2016)
The role of NPY in learning and memory
C. R. Gotzsche et al.
NEUROPEPTIDES (2016)
Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease
Sara P. C. Paiva et al.
NEUROPEPTIDES (2016)
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
Bernard Pereira et al.
NATURE COMMUNICATIONS (2016)
Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers
Christopher A. Miller et al.
Nature Communications (2016)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
Endocrine resistance in breast cancer - An overview and update
Robert Clarke et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Synthesis and in Vitro and in Vivo Evaluation of an 18F-Labeled Neuropeptide Y Analogue for Imaging of Breast Cancer by PET
Sven Hofmann et al.
MOLECULAR PHARMACEUTICS (2015)
Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
Prudence A. Francis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Systemic Levels of Neuropeptide Y and Dipeptidyl Peptidase Activity in Patients With Ewing Sarcoma-Associations With Tumor Phenotype and Survival
Jason U. Tilan et al.
CANCER (2015)
The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication
Mathias Rask-Andersen et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance
Gladys Morrison et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives with Bombesin, Neurotensin, and Neuropeptide-Y Receptors
Clement Morgat et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Molecular signatures of G-protein-coupled receptors
A. J. Venkatakrishnan et al.
NATURE (2013)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
G protein-coupled receptor kinases: More than just kinases and not only for GPCRs
Eugenia V. Gurevich et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Mechanisms of Endocrine Resistance in Breast Cancer
C. Kent Osborne et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Biological mechanisms and clinical implications of endocrine resistance in breast cancer
Mario Giuliano et al.
BREAST (2011)
Trends in the exploitation of novel drug targets
Mathias Rask-Andersen et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Phosphorylation Barcoding as a Mechanism of Directing GPCR Signaling
Stephen B. Liggett
SCIENCE SIGNALING (2011)
Breast-Cancer Diagnosis by Neuropeptide Y Analogues: From Synthesis to Clinical Application
Irfan U. Khan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu et al.
SCIENCE (2010)
G-protein Coupled Receptors in Stem Cell Self-Renewal and Differentiation
Nao R. Kobayashi et al.
STEM CELL REVIEWS AND REPORTS (2010)
Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease
Fionnuala T. Lundy et al.
ARCHIVES OF ORAL BIOLOGY (2009)
Gi-Coupled GPCR Signaling Controls the Formation and Organization of Human Pluripotent Colonies
Kenta Nakamura et al.
PLOS ONE (2009)
Neuropeptide Y Gene Polymorphisms Confer Risk of Early-Onset Atherosclerosis
Svati H. Shah et al.
PLOS GENETICS (2009)
G protein-coupled receptor sorting to endosomes and lysosomes
Adriano Marchese et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
G-protein-coupled receptor phosphorylation: where, when and by whom
A. B. Tobin
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts
Chad J. Creighton et al.
CANCER RESEARCH (2008)
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function
Suleiman Massarweh et al.
CANCER RESEARCH (2008)
Structural diversity of G protein-coupled receptors and significance for drug discovery
Malin C. Lagerstrom et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome
Lydia E. Kuo et al.
NATURE MEDICINE (2007)
GPR30: A G protein-coupled receptor for estrogen
Eric R. Prossnitz et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
G-protein-coupled receptors and cancer
Robert T. Dorsam et al.
NATURE REVIEWS CANCER (2007)
Opinion - How many drug targets are there?
John P. Overington et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Estrogen up-regulates neuropeptide YY1 receptor expression in a human breast cancer cell line
H Amlal et al.
CANCER RESEARCH (2006)
Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors
Chad J. Creighton et al.
GENOME BIOLOGY (2006)
Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells
A Pébay et al.
STEM CELLS (2005)
Tamoxifen: A most unlikely pioneering medicine
VC Jordan
NATURE REVIEWS DRUG DISCOVERY (2003)
Transcription factors as targets for cancer therapy
JE Darnell
NATURE REVIEWS CANCER (2002)
分享论文
